Abstract
Receptor-mediated tumor targeting has received major attention in the field of cancer drug delivery in the past few years. Receptors, as molecular target has opened new opportunities for cellular or intracellular targeting of drug loaded delivery systems conjugated with targeting moieties i.e. ligand. This receptor mediated targeting of cancer drug through nano carrier systems to cancerous tissue offer protection and improves the pharmacokinetics of various drugs and help to overcome the systemic toxicity and adverse effects that result from the non-selective nature of most current cancer therapeutic agents. The article reviews the scope of receptor mediated targeting of anticancer drug loaded in various nanocarriers and also summarize recent perspective and challenges in the field of nanocarrier-aided drug delivery and drug targeting for cancer therapy.
Keywords: Receptor, ligand, nanocarrier, tumor targeting, vascular endothelial growth factor, basic fibroblast growth factor, diapedesis, enhanced permeability and retention, prostate-specific membrane antigens, lysosomes, transferrin receptor, apotransferrin, ferrotransferrin, Tf-coupled poly(ethylene glycol), PEG stealth liposomes, Artemisinin, folate receptor, docetaxel, polymer arabinogalactan, methotrexate, transforming growth factor-, amphiregulin, betacellulin, heparin-binding EGF, glycerol monooleate coated magnetic nanoparticles, boron neutron capture therapy, Bevacizumab, doxorubicin, Isoaspartate-glycine-arginine, doxorubicin-loaded immunoliposomes, Intercellular cell adhesion molecule-1, Prostate specific membrane antigen
Current Drug Delivery
Title: Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Volume: 8 Issue: 1
Author(s): Chandana Mohanty, Manasi Das, Jagat R. Kanwar and Sanjeeb K. Sahoo
Affiliation:
Keywords: Receptor, ligand, nanocarrier, tumor targeting, vascular endothelial growth factor, basic fibroblast growth factor, diapedesis, enhanced permeability and retention, prostate-specific membrane antigens, lysosomes, transferrin receptor, apotransferrin, ferrotransferrin, Tf-coupled poly(ethylene glycol), PEG stealth liposomes, Artemisinin, folate receptor, docetaxel, polymer arabinogalactan, methotrexate, transforming growth factor-, amphiregulin, betacellulin, heparin-binding EGF, glycerol monooleate coated magnetic nanoparticles, boron neutron capture therapy, Bevacizumab, doxorubicin, Isoaspartate-glycine-arginine, doxorubicin-loaded immunoliposomes, Intercellular cell adhesion molecule-1, Prostate specific membrane antigen
Abstract: Receptor-mediated tumor targeting has received major attention in the field of cancer drug delivery in the past few years. Receptors, as molecular target has opened new opportunities for cellular or intracellular targeting of drug loaded delivery systems conjugated with targeting moieties i.e. ligand. This receptor mediated targeting of cancer drug through nano carrier systems to cancerous tissue offer protection and improves the pharmacokinetics of various drugs and help to overcome the systemic toxicity and adverse effects that result from the non-selective nature of most current cancer therapeutic agents. The article reviews the scope of receptor mediated targeting of anticancer drug loaded in various nanocarriers and also summarize recent perspective and challenges in the field of nanocarrier-aided drug delivery and drug targeting for cancer therapy.
Export Options
About this article
Cite this article as:
Mohanty Chandana, Das Manasi, R. Kanwar Jagat and K. Sahoo Sanjeeb, Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy, Current Drug Delivery 2011; 8 (1) . https://dx.doi.org/10.2174/156720111793663606
DOI https://dx.doi.org/10.2174/156720111793663606 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
Current Drug Metabolism ULK1 Plays a Critical Role in AMPK-Mediated Myocardial Autophagy and Contractile Dysfunction following Acute Alcohol Challenge
Current Pharmaceutical Design Chagas Disease Chemotherapy: What Do We Know So Far?
Current Pharmaceutical Design Protecting the Heart: Biological Targets and Clinical Strategies
Current Pharmaceutical Design Telmisartan in the Management of Diabetic Nephropathy: A Contemporary View
Current Diabetes Reviews The Pathophysiology of Heart Failure in Children: The Basics
Current Cardiology Reviews Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry Targeting Drugs to APJ Receptor: The Prospect of Treatment of Hypertension and Other Cardiovascular Diseases
Current Drug Targets Signaling Epicenters: The Role of Caveolae and Caveolins in Volatile Anesthetic Induced Cardiac Protection
Current Pharmaceutical Design Rheumatoid Arthritis: An Autoimmune Disease with Female Preponderance and Cardiovascular Risk Equivalent to Diabetes Mellitus: Role of Cardiovascular Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Vascular Disease and Risk Factors in Chronic Kidney Disease
Vascular Disease Prevention (Discontinued) S100A1: Structure, Function, and Therapeutic Potential
Current Chemical Biology New Trends and Advances in Oral and Maxillofacial Imaging
Current Medical Imaging Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications
Current Pharmaceutical Design QT Prolongation and Safety in the Indian Population
Current Drug Safety Fetal Risks of Maternal Diabetes
Current Women`s Health Reviews Clinical Implications of Recent Insights into the Structural Biology of Beta2 Adrenoceptors
Current Drug Targets Heart Failure Modulates the Muscle Reflex
Current Cardiology Reviews The Application of NMR Spectroscopy for the Study of Heart Failure
Current Pharmaceutical Design Advent and Maturation of Regenerative Medicine
Current Stem Cell Research & Therapy